Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

Kathrine Lederballe Grøn

Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

Kathrine Lederballe Grøn

Department for Rheumatology and Spine Diseases

Original language	English

Number of pages	133
Publication status	Published - 2019

Cite this

@phdthesis{b176a9154844408288218e91b92af003,

title = "Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.",

author = "Gr{\o}n, {Kathrine Lederballe}",

note = "COPECARE",

year = "2019",

language = "English",

}

TY - BOOK

T1 - Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

AU - Grøn, Kathrine Lederballe

N1 - COPECARE

PY - 2019

Y1 - 2019

M3 - Ph.D. thesis

BT - Infection risk and treatment effectiveness in patients with rheumatoid arthritis initiating therapy with biologic disease modifying antirheumatic drugs. Epidemiological studies based on data from DANBIO and national registries.

ER -